Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity-Reference-Cited by-同舟云学术

Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity

Published:2015-05 Issue:5 Volume:122 Page:1008-1015
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Hwang Christopher K.,Hubbard G. Baker,Hutchinson Amy K.,Lambert Scott R.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference41 articles.

1. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity;Alon;Nat Med,1995

2. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo;Kim;Nature,1993

3. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization;Pierce;Proc Natl Acad Sci U S A,1995

4. Mechanisms and management of retinopathy of prematurity;Hartnett;N Engl J Med,2012

5. Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: 3-year outcome;White;J Pediatr Ophthalmol Strabismus,1997

Cited by 181 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Animal Models of Retinopathy of Prematurity: Advances and Metabolic Regulators;Biomedicines;2024-08-23

2. Six years follow-up of type 1 retinopathy of prematurity (ROP) treated with intravitreal injection of ranibizumab and bevacizumab: Long-Term Outcomes of intravitreal injection in Type 1 ROP;Medicine;2024-08-09

3. Analysis of research hotspots and trends in pediatric ophthalmopathy based on 10 years of WoSCC literature;Frontiers in Pediatrics;2024-05-30

4. Non-surgical treatment of stage 4A retinopathy of prematurity;BMC Ophthalmology;2024-04-19

5. Management of retinopathy of pre-maturity – Beyond the known;Indian Journal of Ophthalmology - Case Reports;2024-04